Nonclinical Pharmacokinetics Study of OLX702A-075-16, N-Acetylgalactosamine Conjugated Asymmetric Small Interfering RNA (GalNAc-asiRNA)
Drug Metabolism and Disposition · 2024
DOI: 10.1124/dmd.124.001805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024. Verfasst von Jihye Ban und 8 weiteren Autor:innen. Beteiligte Einrichtung: OliX Pharmaceuticals, Inc., Suwon, South Korea (J.B., B.K.S., Y.Y., M.K., J.C., J.H.P., S.-Y.P., D.-K.L.) and College of Pharmacy and Research Instit…. Hauptthemen laut MEDLINE: Acetylgalactosamine, RNA, Small Interfering. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- OliX Pharmaceuticals, Inc., Suwon, South Korea (J.B., B.K.S., Y.Y., M.K., J.C., J.H.P., S.-Y.P., D.-K.L.) and College of Pharmacy and Research Institute of Pharmaceutical Science and Technology, Ajou University, Suwon,…
Zitieren
APA
Ban, J., Seo, B. K., Yu, Y., Kim, M., Choe, J., Park, J. H., Park, S. Y., Lee, D. K., & Kim, S. H. (2024). Nonclinical Pharmacokinetics Study of OLX702A-075-16, N-Acetylgalactosamine Conjugated Asymmetric Small Interfering RNA (GalNAc-asiRNA). Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.124.001805
Vancouver
Ban J, Seo BK, Yu Y, Kim M, Choe J, Park JH, et al. Nonclinical Pharmacokinetics Study of OLX702A-075-16, N-Acetylgalactosamine Conjugated Asymmetric Small Interfering RNA (GalNAc-asiRNA). Drug Metabolism and Disposition. 2024. doi:10.1124/dmd.124.001805
BibTeX
@article{Ban2024,
author = {Ban, Jihye and Seo, Bong Kyo and Yu, Yunmi and Kim, Minkyeong and Choe, Jeongyong and Park, June Hyun and Park, Shin-Young and Lee, Dong-Ki and Kim, So Hee},
title = {Nonclinical Pharmacokinetics Study of OLX702A-075-16, N-Acetylgalactosamine Conjugated Asymmetric Small Interfering RNA (GalNAc-asiRNA)},
journal = {Drug Metabolism and Disposition},
year = {2024},
doi = {10.1124/dmd.124.001805}
}
EUVIMED